Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...
TARRYTOWN, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Jefferies London Healthcare Conference at 3:30 p.m.
Additionally, the more than 50 abstracts accepted at ASH include new and updated data from Incyte’s MPN, GVHD and hematology ...
The Unfiltered Investor brings a refreshing edge, designed to help readers navigate today’s AI-driven volatility with ...
Investing.com -- TuHURA Biosciences Inc (NASDAQ:HURA) stock gained 2.8% premarket Monday after the company announced its research on the Delta Opioid Receptor (DOR) in cancer immunotherapy was ...
As the Minister of Finance, Dr Cassiel Ato Forson, prepares for the 2026 budget reading in Parliament, the Food and Beverages ...
ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback